Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/24/2014US8758819 Cosmetic compositions for the treatment of skin and methods thereof
06/24/2014US8758817 Dosage form containing (S)-pantoprazole as active ingredient
06/24/2014US8758813 Abuse-deterrent drug formulations
06/24/2014US8758811 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery
06/24/2014US8758808 Method of making a high enhancer-loading polyacrylate formulation for transdermal applications
06/24/2014US8758804 Controlled and continued delivery of rifaximin and/or other substances
06/24/2014US8758802 Methods of inhibiting cataracts and presbyopia
06/24/2014US8758795 Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
06/24/2014US8758789 Medium chain peroxycarboxylic acid compositions
06/24/2014US8758788 Fungicidally active compound combinations
06/24/2014US8758786 Preparation for reducing and/or preventing body fat and respective uses, in particular together with a dressing material
06/24/2014US8758785 Composition for external use and method for producing the same
06/24/2014US8758784 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
06/24/2014US8758779 Pharmaceutical composition of duloxetine
06/24/2014US8758777 Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof
06/24/2014US8758776 Compositions and methods for treatment
06/24/2014US8758753 Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors
06/24/2014US8758747 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
06/24/2014US8758743 Compositions containing coenzyme Q10
06/24/2014US8758740 Composition for promoting ketone body production
06/24/2014US8758739 Cosmetic compositions containing block copolymers, tackifiers and gelling agents
06/24/2014US8758738 Methods for sealing wounds with a sterilized composition of a cyanoacrylate monomer and a poloxamer
06/24/2014US8758737 Evaporative cooling composition
06/24/2014US8758728 Foamable suspension gel
06/24/2014US8758286 Method for removing cytokines from blood with surface immobilized polysaccharides
06/21/2014CA2836388A1 Neuroprotection and myelin repair using st-1435
06/19/2014WO2014093960A1 Compositions and methods for treating disease
06/19/2014WO2014093941A1 Pharmaceutical compositions
06/19/2014WO2014093907A1 Pharmaceutical composition comprising antiemetic compounds and polyorthoester
06/19/2014WO2014093901A1 Triheptanoin for the treatment of glucose transporter 1 deficiency
06/19/2014WO2014093871A1 Methods for treating pruritus
06/19/2014WO2014093869A1 6-substituted quinazolinone inhibitors
06/19/2014WO2014093818A2 Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
06/19/2014WO2014093815A1 Anthracycline formulations
06/19/2014WO2014093791A1 Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
06/19/2014WO2014093773A1 Methods and assays relating to macrophage differentiation
06/19/2014WO2014093750A1 Method of administration and treatment
06/19/2014WO2014093726A1 Methods of treating portal hypertension
06/19/2014WO2014093711A1 Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity
06/19/2014WO2014093690A1 Modified axl peptides and their use in inhibition of axl signaling in anti-metastatic therapy
06/19/2014WO2014093675A1 Porphyrin modified telodendrimers
06/19/2014WO2014093652A1 Semi - synthetic mithramycin derivatives with anti-cancer activity
06/19/2014WO2014093645A2 Topical formulations for increasing the dermal concentration of hyaluronic acid
06/19/2014WO2014093632A2 Use of cyclophilin d inhibitors to treat or prevent bone disorders
06/19/2014WO2014093606A1 Pyridone derivatives and uses thereof in the treatment of tuberculosis
06/19/2014WO2014093583A2 Synthetic methods for preparing 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, other salt forms of this compound and intermediates thereof
06/19/2014WO2014093579A2 Crystalline forms of 3-(imidazo[1,2-b] pyridazin-3-ylethynyl)-4-methyl-n-(4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl)benzamide and its mono hydrochloride salt
06/19/2014WO2014093557A1 Methods and compositions comprising akt inhibitors and/or phospholipase d inhibitors
06/19/2014WO2014093537A1 Competitive modulation of micrornas
06/19/2014WO2014093531A1 Modulation of myofiber repair by anti-myostatin in strategies with stem cells
06/19/2014WO2014093481A1 Phenylpyrazole injectable compositions
06/19/2014WO2014093475A1 Methods for treating parkinson's disease using aminopyridines
06/19/2014WO2014093383A1 Substituted 1h-pyrrolo [2,3-b] pyridine and 1h-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (sik2) inhibitors
06/19/2014WO2014093337A1 Diazepine derivatives useful as calcium channel blockers in the treatment of pain
06/19/2014WO2014093313A1 Compositions and methods for integrated metabolic interventions
06/19/2014WO2014093305A2 Micrornas and uses thereof
06/19/2014WO2014093277A1 Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
06/19/2014WO2014093253A1 Novel aromatic thio compounds as receptor modulators
06/19/2014WO2014093230A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
06/19/2014WO2014093228A1 Antagonizing heparin with salicylamide compounds and antihistamines
06/19/2014WO2014093191A1 AMINO-PYRIMIDINE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
06/19/2014WO2014093190A1 Bace inhibitors of iminothiadiazine dioxides
06/19/2014WO2014093189A1 Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor
06/19/2014WO2014093114A1 Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases
06/19/2014WO2014093076A1 Cosmetic compositions with near infra-red (nir) light - emitting material and methods therefor
06/19/2014WO2014093075A1 Cosmetic compositions with near infra-red (nir) light - emitting material and methods therefor
06/19/2014WO2014093074A1 Cosmetic compositions with near infra-red (nir) light - emitting material and methods therefor
06/19/2014WO2014093071A1 Cosmetic compositions with near infra-red (nir) light-emitting material and methods therefor
06/19/2014WO2014093031A1 Bacteria targeting nanoparticles and related methods of use
06/19/2014WO2014092958A1 Compositions and methods of diagnosing ocular diseases
06/19/2014WO2014092751A1 Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios
06/19/2014WO2014092747A1 Metal oxide complexes and infusion of complexes into polymer compounds
06/19/2014WO2014092661A1 Particulate formulations of tadalafil in effervescent form
06/19/2014WO2014092589A1 Process for preparation of prasugrel hydrochloride polymorphic form b of pharmaceutical purity
06/19/2014WO2014092572A1 Improved methods for cancer treatment with a genotoxic agent
06/19/2014WO2014092564A1 Nutritional composition with non digestible oligosaccharides
06/19/2014WO2014092532A1 Anti-proliferative effects of palm vegetation liquor and extracts thereof in preventing pancreatic cancer
06/19/2014WO2014092514A1 Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
06/19/2014WO2014092498A1 Conjugate of vitamin c and vitamin b3, and antioxidant containing same
06/19/2014WO2014092489A1 Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient
06/19/2014WO2014092480A1 Conjugate of vitamin c and vitamin e, and antioxidant containing same
06/19/2014WO2014092358A1 Chewable tablet comprising a phosphodiesterase-5 inhibitor
06/19/2014WO2014092346A1 Bitter taste masked pharmaceutical formulation comprising corticosteroid, antihistamine and stevia
06/19/2014WO2014092325A1 Skin-moisturising or wrinkle-improving external composition and cosmetic composition
06/19/2014WO2014092175A1 Specific polyphenol used in food and drink products, supplements, pharmaceuticals, and the like and method for manufacturing said specific polyphenol
06/19/2014WO2014092166A1 Tyrosinase activity inhibitor and whitening agent
06/19/2014WO2014092154A1 Prevention or treatment agent for hepatic fibrosis
06/19/2014WO2014092104A1 Oxadiazole derivative and pharmaceutical use of same
06/19/2014WO2014092100A1 Heterocyclic compound
06/19/2014WO2014092061A1 Hydantoin derivative
06/19/2014WO2014092007A1 Hair growing agent
06/19/2014WO2014092006A1 Novel octahydropyridoquinazoline derivative, pharmaceutical composition containing same, and uses for said derivative and composition
06/19/2014WO2014091980A1 Hyaluronic acid composition
06/19/2014WO2014091876A1 Fluorine-substituted piperidine compound
06/19/2014WO2014091486A1 Combination therapy for cancer
06/19/2014WO2014091446A1 Pyrimido [4,5-b]quinoline-4,5 (3h,10h)-diones as nonsense mutation suppressors
06/19/2014WO2014091443A1 Cathepsin c inhibitors for treating cystic fibrosis, non-cystic fibrosis bronchiectasis, and anca-associated vasculitis
06/19/2014WO2014091437A1 Oral form, comprising immediate-release coated particles of at least one active compound that are grinding-resistant
06/19/2014WO2014091436A1 Nanoparticles based on a gag and a squalene
06/19/2014WO2014091432A1 Pharmaceutical compositions of rifaximin
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 7860